Novo Nordisk is expanding its cardiometabolic drug pipeline with the acquisition of Embark Biotech, a startup developing drugs for a novel target that can suppress appetite and boost calorie burning in cells. Embark’s science comes University of Copenhagen research on a novel fat cell target.
While Medtronic (MDT) is at work to launch its new artificial pancreas system, researchers at the University of Copenhagen have come up with a new 3-D method with potential to create mini human pancreas. It would be used to fight diabetes, allowing drugs to be tested quickly without using animals. The process uses a 3-D […]
3D medical animation services have emerged as a groundbreaking tool in the healthcare industry, revolutionizing the way medical concepts are taught, understood, and marketed.